Dual-Nozzle 3D Printed Nano-Hydroxyapatite Scaffold Loaded with Vancomycin Sustained-Release Microspheres for Enhancing Bone Regeneration
Jianyi Li,Keke Li,Yukun Du,Xiaojie Tang,Chenjing Liu,Shannan Cao,Baomeng Zhao,Hai Huang,Hongri Zhao,Weiqing Kong,Tongshuai Xu,Cheng Shao,Jiale Shao,Guodong Zhang,Hongbo Lan,Yongming Xi
DOI: https://doi.org/10.2147/IJN.S394366
IF: 7.033
2023-01-18
International Journal of Nanomedicine
Abstract:Jianyi Li, 1, &ast Keke Li, 2, &ast Yukun Du, 1, &ast Xiaojie Tang, 3, &ast Chenjing Liu, 1 Shannan Cao, 3 Baomeng Zhao, 2 Hai Huang, 3 Hongri Zhao, 3 Weiqing Kong, 1 Tongshuai Xu, 3 Cheng Shao, 1 Jiale Shao, 1 Guodong Zhang, 4 Hongbo Lan, 5 Yongming Xi 1 1 Department of Orthopaedic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China; 2 Yantai Campus of Binzhou Medical University, Yantai, People's Republic of China; 3 Yantai Affiliated Hospital of Binzhou Medical University, Yantai, People's Republic of China; 4 Tengzhou Central People's Hospital, Tengzhou, People's Republic of China; 5 Shandong Engineering Research Center for Additive Manufacturing Qingdao University of Technology, Qingdao, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yongming Xi, Department of Orthopaedic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, 266071, People's Republic of China, Email Hongbo Lan, Shandong Engineering Research Center for Additive Manufacturing Qingdao University of Technology, Qingdao, 266520, People's Republic of China, Email Background: Successful treatment of infectious bone defect remains a major challenge in the orthopaedic field. At present, the conventional treatment for infectious bone defects is surgical debridement and long-term systemic antibiotic use. It is necessary to develop a new strategy to achieve effective bone regeneration and local anti-infection for infectious bone defects. Methods: Firstly, vancomycin / poly (lactic acid-glycolic acid) sustained release microspheres (VAN/PLGA-MS) were prepared. Then, through the dual-nozzle 3D printing technology, VAN/PLGA-MS was uniformly loaded into the pores of nano-hydroxyapatite (n-HA) and polylactic acid (PLA) scaffolds printed in a certain proportion, and a composite scaffold (VAN/MS-PLA/n-HA) was designed, which can not only promote bone repair but also resist local infection. Finally, the performance of the composite scaffold was evaluated by in vivo and in vitro biological evaluation. Results: The in vitro release test of microspheres showed that the release of VAN/PLGA-MS was relatively stable from the second day, and the average daily release concentration was about 15.75 μg/mL, which was higher than the minimum concentration specified in the guidelines. The bacteriostatic test in vitro showed that VAN/PLGA-MS had obvious inhibitory effect on Staphylococcus aureus ATCC-29213. Biological evaluation of VAN/MS-PLA/n-HA scaffolds in vitro showed that it can promote the proliferation of adipose stem cells. In vivo biological evaluation showed that VAN/MS-PLA/n-HA scaffold could significantly promote bone regeneration. Conclusion: Our research shows that VAN/MS-PLA/n-HA scaffolds have satisfying biomechanical properties, effectively inhibit the growth of Staphylococcus aureus, with good biocompatibility, and effectiveness on repairing bone defects. The VAN/MS-PLA/n-HA scaffold provide the clinic with an application prospect in bone tissue engineering. Graphical Keywords: osteogenesis, dual-nozzle 3D printing technology, drug-loaded microspheres, vancomycin, nano-hydroxyapatite Graphical Bone defects, which are the most common problems encountered by orthopaedic surgeons, are mainly caused by trauma, infection, tumours, and degeneration, and they often manifest as pain at the defect site, limb dysfunction, and so on, which seriously affect patient quality of life. 1–3 As the bone tissue has a certain ability to regenerate, most fractures or minor bone defects can gradually recover without intervention; however, if the bone defect is too large and exceeds the 'critical range of bone defects', it cannot heal itself and must be repaired and reconstructed. 4,5 According to statistics, more than 500,000 patients need bone transplants each year in the United States alone, second only to blood cell transplants. 6,7 In addition, the large bone defects are often accompanied by a high risk of infection. 8 Pathogenic bacteria can significantly destroy local tissue and bone regeneration ability, causing local blood damage and osteonecrosis, systemic application of antibiotics is difficult to achieve effective drug concentration at the infected site, which delayed bone healing, nonunion or even amputation. 9–11 At present, the clinical materials for repairing bone defects include not only autogenous bone but als -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology